Gao, Chao
He, Xingqiang
Liu, Yunpeng
Liu, Jianzheng
Jiang, Zhiwei
Zhu, Bin
Qin, Xing
Xia, Yunlong
Zhang, Tingting
Wang, Ping
Zhang, Ruining
Onuma, Yoshinobu
Xia, Jielai
Wang, Duolao
Serruys, Patrick
Tao, Ling
Funding for this research was provided by:
Xijing hospital (XJZT24LY36)
Article History
Received: 16 February 2024
Accepted: 10 June 2024
First Online: 24 June 2024
Declarations
:
: This study will be conducted according to the principles outlined in the Declaration of Helsinki, the Ethical Guidelines for Medical and Health Research Involving Human Subjects, and all other applicable laws and regulations in China. All patients must provide written informed consent. The institutional review board at Xijing Hospital (KY20202070-C-1) and the other 43 participating centers in China have approved this study protocol.
: The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This trial is investigator-initiated and obtained grant support from Xijing Hospital (Xi’an, China; Grant No. XJZT24LY36) and unrestricted grant support from Shenqi Medical (Shanghai, China) and Microport Medical Group (Shanghai, China). Apart from this sponsorship, Shenqi and Microport were not involved in the design, execution, or decision to publish the study.